The core products of this cooperation are Retatrutide 10mg and NAD+ 500mg, both high-quality biotechnological and chemical products independently developed and manufactured by our company, BLOOM TECH. With strict quality control and stable product performance, they have gained recognition from customers in many countries around the world.
|
|
|
|
|
|
|
|
Retatrutide 10mg is a novel polypeptide compound produced via lyophilization technology and packaged in blue-capped vials. With a purity of over 99% and an accurate specification of 10 mg per box, it maximizes the retention of biological activity and enables convenient long-term storage under room temperature and light-proof conditions.
NAD+ 500mg, full name Nicotinamide Adenine Dinucleotide (also known as Coenzyme I), is also lyophilized and packaged in green-capped vials, with a specification of 500 mg per box. It meets international purity standards, contains no harmful additives, and directly satisfies diverse applications including scientific research and personalized nutritional intervention.
Both products have passed authoritative third-party testing with complete quality inspection reports and demonstrate excellent stability in cross-border transportation, laying a solid foundation for the smooth cooperation with the Indonesian customer.The customer is from Indonesia. After learning about Retatrutide 10mg and NAD+ 500mg through our official website and the dedicated peptide product website, the customer proactively contacted our sales team to inquire about product details and cross-border delivery feasibility.
In the early stage, the customer focused on confirming the safe delivery plan, transportation timeliness, and payment methods for lyophilized peptide vials. Our team patiently answered all questions, elaborated on packaging protection measures and the advantages of our dedicated international special cargo logistics lines, and provided flexible payment options.
After brief communication, the customer confirmed an order for 1 box of Retatrutide 10mg and 1 box of NAD+ 500mg. The total price agreed by both parties was 373 US dollars (including 85 US dollars for international shipping), and the customer chose to pay via cryptocurrency.We promptly provided a USDT wallet address under the TRC20 protocol, and the customer completed the transfer of 374 Tether (including 1 Tether for network fees) within one week. Immediately after verifying the receipt, we quickly finished goods packaging, logistics label completion, and shipped via our dedicated international special cargo line.
The goods were safely delivered to the customer's designated address in Kota Baru, Banten Province, Indonesia within the promised timeframe of 6–9 days. After confirming the goods were intact, the customer expressed satisfaction with the cooperation and clearly stated intentions to place follow-up orders for other peptide products such as BPC157 and TB500 for long-term stable cooperation.
I. Retatrutide 10mg: Applications and Development Prospects of a Novel Polypeptide Compound
(I) Core Applications of Retatrutide 10mg
As an investigational novel triple hormone receptor agonist, Retatrutide 10mg is a single molecule that simultaneously activates human GIP (Glucose-dependent Insulinotropic Polypeptide), GLP-1 (Glucagon-like Peptide-1), and glucagon receptors. It is currently mainly used in scientific research and preclinical trials, providing important material support for related disease research.
In obesity research, it shows significant weight-loss potential. Preclinical data indicate that it regulates hormone levels, suppresses appetite, increases energy expenditure, and improves lipid metabolism disorders, offering a new direction for obesity treatment research.
In metabolic disease research, Retatrutide 10mg is highly significant for studies on type 2 diabetes and metabolic syndrome. It improves insulin sensitivity and glycemic control and reduces the risk of complications such as fatty liver. Relevant findings have been published in internationally authoritative medical journals, laying groundwork for future clinical applications.
Additionally, it is used in clinical studies of knee osteoarthritis, moderate to severe obstructive sleep apnea, and chronic lower back pain, potentially providing new therapeutic targets. It also supports peptide structure–function analysis in academic research, guiding the development of peptide drugs.
(II) Development Prospects of Retatrutide 10mg
With the rising global incidence of obesity, type 2 diabetes, and other metabolic diseases, demand for novel therapeutic and research reagents continues to grow. Retatrutide 10mg, as a highly promising polypeptide compound, has broad development prospects.
According to market research reports, the global Retatrutide market size is projected to grow from 1.348 billion US dollars in 2025 to 4.578 billion US dollars in 2032, with a compound annual growth rate (CAGR) of 18.5%, showing strong growth momentum.
Currently, Retatrutide is in Phase III clinical trials led by Eli Lilly and Company. Following successful clinical completion and regulatory approval, it will be officially launched, expanding applications from research to clinical therapy and triggering explosive demand growth.
Southeast Asia, a region with a high prevalence of metabolic diseases, represents a growing market. The order from the Indonesian customer directly reflects this regional demand.
Furthermore, advancements in peptide synthesis technology will gradually reduce production costs and improve cost-effectiveness, while expanding applications into anti-aging cosmetics and sports nutrition.
With mature lyophilization technology and strict quality control, BLOOM TECH has achieved large-scale production of Retatrutide 10mg, capable of meeting global research and related demands and maintaining a competitive edge in the global market.
II. NAD+ 500mg: Applications and Development Prospects of a Core Cellular Health Substance
(I) Core Applications of NAD+ 500mg
As an indispensable "vital coenzyme" in every human cell, NAD+ 500mg is mainly used in cellular energy metabolism, cell repair, and health maintenance, with wide applications in scientific research and personalized nutritional intervention.
In cellular energy metabolism, NAD+ is a key coenzyme in the tricarboxylic acid cycle and oxidative phosphorylation. It directly participates in converting glucose and fat into ATP (cellular energy currency), significantly improving mitochondrial energy production, relieving fatigue and energy decline, especially for people under high pressure and irregular schedules.
In cell repair, NAD+ fuels DNA repair enzymes (e.g., the PARP family) and sirtuins (Sirtuins 1–7), effectively repairing DNA damage and delaying cellular senescence. Studies show that restoring NAD+ homeostasis reverses brain DNA damage, reduces Tau protein tangles, and benefits cognitive function.
For middle-aged and elderly people, NAD+ 500mg slows aging and improves degenerative symptoms such as memory loss and joint stiffness. For those with metabolic disorders, it activates the SIRT1 pathway, enhances insulin sensitivity, stabilizes blood sugar, and reduces visceral fat accumulation. For fertility-preparing individuals, it repairs mitochondrial function, reduces oocyte DNA damage, and improves conception success rates.
NAD+ 500mg also boosts immunity by optimizing immune cell function: enhancing macrophage phagocytosis and T-cell killing accuracy while avoiding excessive inflammation, making it effective for people with low immunity and recurrent respiratory infections.
In scientific research, it is widely used in cell biology, aging mechanisms, and neurodegenerative disease studies, providing critical experimental reagents for researchers.
(II) Development Prospects of NAD+ 500mg
In recent years, with rising health awareness, anti-aging and cellular health have become global consumption hotspots. As a core substance for cellular health, NAD+ has seen rapidly growing demand and broad prospects.
According to industry reports, the global NAD+ market was valued at 1.2 billion US dollars in 2024 and is expected to grow at a CAGR of 8.7% from 2026 to 2033, reaching 2.5 billion US dollars by 2033.
The consumer base is expanding from the middle-aged and elderly to working professionals, fertility-preparing individuals, and sports enthusiasts, showing diversified demand.
Southeast Asia, a densely populated and rapidly developing region, has increasing health consumption capacity and strong demand for NAD+-based health products. The Indonesian order reflects the huge regional market potential.
Technologically, advances in synthetic biology have optimized production processes, lowered costs, and improved purity and stability, supporting large-scale applications.
Although global competition in NAD+ products is intensifying, BLOOM TECH maintains advantages through advanced production technology, strict quality control, and a complete cross-border service system, providing high-quality NAD+ 500mg and professional services.
In the future, deeper research will expand NAD+ applications into cardiovascular protection and neurodegenerative disease treatment. Meanwhile, the growth of cross-border e-commerce and diversified payment methods will expand global market coverage, creating more cooperation opportunities.
III. Cooperation Insights and Future Outlook
This cooperation with the Indonesian customer marks an important step for Retatrutide 10mg and NAD+ 500mg into the Southeast Asian market and fully demonstrates our cross-border service capabilities.
The customer's choice of cryptocurrency (USDT) payment aligns with the trend of diversified cross-border trade payments. Supported by flexible payment options, efficient logistics, and high-quality products, we successfully completed the cooperation, gained customer trust, and laid a foundation for further expanding the Southeast Asian market and building long-term partnerships.
This cooperation confirms that high-quality products are the core foundation of cooperation, while flexible payments, efficient cross-border logistics, and professional services are critical to improving customer experience and securing deals. Providing customized solutions for customers from different countries effectively enhances cooperation success and achieves mutual benefit.
In the future, BLOOM TECH will continue to focus on the R&D and production of peptides and coenzymes including Retatrutide and NAD+, constantly improving product quality and expanding applications to meet global diversified demands.
We will further optimize the cross-border logistics system, enhance payment support, improve service efficiency and quality, and strengthen cooperation worldwide-with a special focus on the Southeast Asian market.
By delivering more high-quality products globally and providing premium services, we will achieve common development with customers worldwide.
